Jo P. Pauls
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jo P. Pauls has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Shaun David Gregory
Advanced Cardiorespiratory Engineering Laboratory, Faculty of Engineering Queensland University of Technology Brisbane Australia
19 shared publications John F. Fraser
Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group The Prince Charles Hospital Brisbane Queensland Australia
16 shared publicationsGeoff Tansley
School of Engineering and Built Environment, Griffith University, Southport, Australia
15 shared publications- Michael Charles Stevens
School of Biomedical Engineering, Faculty of Engineering, UNSW, Sydney, NSW, 2052, Australia
11 shared publications - Eric Lee-Jan Wu
Institute for Molecular Bioscience, The University of Queensland Brisbane Queensland Australia
6 shared publications Daniel Timms
CTI, Texas Heart Institute, Houston, TX, USA
4 shared publications
Latest Publications
- 29 September 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (10) , 814-822
In Silico Analysis of Pulsatile Flow Veno-Arterial Extracorporeal Membrane Oxygenation on Human Aorta Model
Electrocardiogram (ECG)—synchronized pulsatile veno-arterial extracorporeal membrane oxygenation (V-A ECMO) is a recent development in extracorporeal therapy for patients with severe cardiogenic shock. Although preclinical studies have shown benefits of pulsatile flow relative to continuous ECMO flow, none have explored the effects of the timing of ECMO pulses with respect to the cardiac cycle and its possible implications on ECMO complications. This study aimed to develop a computational fluid dynamics (CFD) model of V-A ECMO in a patient-specific human aorta and evaluate the effect of ECMO timing on cardiac unloading, surplus hemodynamic energy delivery, and mixing zone position. Using direct flow measurements from cardiogenic shock patients and an ECMO device, the model revealed that maximal left ventricular (LV) unloading occurred when the ECMO pulse was in early diastole (35–40% from LV peak systolic flow). Maximum surplus hemodynamic energy transmission to aortic branches occurred at 20% from LV peak systolic flow. This indicates a trade-off between heart afterload and hemodynamic energy delivery in selecting ECMO pulse timing. The mixing zone was primarily located in the aortic arch across timing configurations. Therefore, selecting ECMO pulse timing is crucial to maximizing the benefits of pulsatile flow in V-A ECMO treatment.
- 29 September 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (10) , 814-822
In Silico Analysis of Pulsatile Flow Veno-Arterial Extracorporeal Membrane Oxygenation on Human Aorta Model
Electrocardiogram (ECG)—synchronized pulsatile veno-arterial extracorporeal membrane oxygenation (V-A ECMO) is a recent development in extracorporeal therapy for patients with severe cardiogenic shock. Although preclinical studies have shown benefits of pulsatile flow relative to continuous ECMO flow, none have explored the effects of the timing of ECMO pulses with respect to the cardiac cycle and its possible implications on ECMO complications. This study aimed to develop a computational fluid dynamics (CFD) model of V-A ECMO in a patient-specific human aorta and evaluate the effect of ECMO timing on cardiac unloading, surplus hemodynamic energy delivery, and mixing zone position. Using direct flow measurements from cardiogenic shock patients and an ECMO device, the model revealed that maximal left ventricular (LV) unloading occurred when the ECMO pulse was in early diastole (35–40% from LV peak systolic flow). Maximum surplus hemodynamic energy transmission to aortic branches occurred at 20% from LV peak systolic flow. This indicates a trade-off between heart afterload and hemodynamic energy delivery in selecting ECMO pulse timing. The mixing zone was primarily located in the aortic arch across timing configurations. Therefore, selecting ECMO pulse timing is crucial to maximizing the benefits of pulsatile flow in V-A ECMO treatment.
- 5 July 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (10) , 1558-1570
Visualizing Flow Dynamics in a Human Aorta During Peripheral Veno‐Arterial Extracorporeal Membrane Oxygenation Treatment Through Particle Image Velocimetry Study
Purpose: To build a mock circulatory loop to simulate veno‐arterial extracorporeal membrane oxygenation (V‐A ECMO) haemodynamics using a patient‐specific silicone aortic phantom and compare the flow dynamics for continuous and pulsatile ECMO settings. Methods: A silicone model of a human aorta with major branches was fabricated and the left iliac artery was cannulated using a Xenios ECMO device to simulate a peripheral V‐A ECMO configuration. The left ventricular outflows at the aortic root were simulated using a piston pump. Particle image velocimetry (PIV) experiments were conducted to measure flow velocities along the aortic phantom for a severe heart failure condition (LV = 1 L/min) supported by ECMO (4 L/min) at a heart rate of 80 bpm. Results: Comparing all ECMO support modes, counter pulse ECMO mode exhibited higher velocities during both peak systolic and mid‐diastolic phases. This shows that the LV and ECMO device supplied fluid into the aorta with less flow resistance, whereas other modes exhibited higher flow resistance due to the flow collision of antegrade LV and retrograde ECMO flow in the aorta. Conclusion: Pulsatile flow ECMO with better placement of ECMO pulse delivery in the cardiac cycle could develop greater pulsatility into the aorta, which is crucial for transferring haemodynamic energy and reducing cardiac afterload.
- 5 July 2025
- Published by Wiley in Artificial Organs
- Vol. 49 (10) , 1558-1570
Visualizing Flow Dynamics in a Human Aorta During Peripheral Veno‐Arterial Extracorporeal Membrane Oxygenation Treatment Through Particle Image Velocimetry Study
Purpose: To build a mock circulatory loop to simulate veno‐arterial extracorporeal membrane oxygenation (V‐A ECMO) haemodynamics using a patient‐specific silicone aortic phantom and compare the flow dynamics for continuous and pulsatile ECMO settings. Methods: A silicone model of a human aorta with major branches was fabricated and the left iliac artery was cannulated using a Xenios ECMO device to simulate a peripheral V‐A ECMO configuration. The left ventricular outflows at the aortic root were simulated using a piston pump. Particle image velocimetry (PIV) experiments were conducted to measure flow velocities along the aortic phantom for a severe heart failure condition (LV = 1 L/min) supported by ECMO (4 L/min) at a heart rate of 80 bpm. Results: Comparing all ECMO support modes, counter pulse ECMO mode exhibited higher velocities during both peak systolic and mid‐diastolic phases. This shows that the LV and ECMO device supplied fluid into the aorta with less flow resistance, whereas other modes exhibited higher flow resistance due to the flow collision of antegrade LV and retrograde ECMO flow in the aorta. Conclusion: Pulsatile flow ECMO with better placement of ECMO pulse delivery in the cardiac cycle could develop greater pulsatility into the aorta, which is crucial for transferring haemodynamic energy and reducing cardiac afterload.
- 27 March 2023
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 69 (5) , e167-e180
Preclinical Studies on Pulsatile Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review
Refractory cardiogenic shock is increasingly being treated with veno-arterial extracorporeal membrane oxygenation (V-A ECMO), without definitive proof of improved clinical outcomes. Recently, pulsatile V-A ECMO has been developed to address some of the shortcomings of contemporary continuous-flow devices. To describe current pulsatile V-A ECMO studies, we conducted a systematic review of all preclinical studies in this area. We adhered to PRISMA and Cochrane guidelines for conducting systematic reviews. The literature search was performed using Science Direct, Web of Science, Scopus, and PubMed databases. All preclinical experimental studies investigating pulsatile V-A ECMO and published before July 26, 2022 were included. We extracted data relating to the 1) ECMO circuits, 2) pulsatile blood flow conditions, 3) key study outcomes, and 4) other relevant experimental conditions. Forty-five manuscripts of pulsatile V-A ECMO were included in this review detailing 26 in vitro, two in silico, and 17 in vivo experiments. Hemodynamic energy production was the most investigated outcome (69%). A total of 53% of studies used a diagonal pump to achieve pulsatile flow. Most literature on pulsatile V-A ECMO focuses on hemodynamic energy production, whereas its potential clinical effects such as favorable heart and brain function, end-organ microcirculation, and decreased inflammation remain inconclusive and limited.
- 27 March 2023
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 69 (5) , e167-e180
Preclinical Studies on Pulsatile Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review
Refractory cardiogenic shock is increasingly being treated with veno-arterial extracorporeal membrane oxygenation (V-A ECMO), without definitive proof of improved clinical outcomes. Recently, pulsatile V-A ECMO has been developed to address some of the shortcomings of contemporary continuous-flow devices. To describe current pulsatile V-A ECMO studies, we conducted a systematic review of all preclinical studies in this area. We adhered to PRISMA and Cochrane guidelines for conducting systematic reviews. The literature search was performed using Science Direct, Web of Science, Scopus, and PubMed databases. All preclinical experimental studies investigating pulsatile V-A ECMO and published before July 26, 2022 were included. We extracted data relating to the 1) ECMO circuits, 2) pulsatile blood flow conditions, 3) key study outcomes, and 4) other relevant experimental conditions. Forty-five manuscripts of pulsatile V-A ECMO were included in this review detailing 26 in vitro, two in silico, and 17 in vivo experiments. Hemodynamic energy production was the most investigated outcome (69%). A total of 53% of studies used a diagonal pump to achieve pulsatile flow. Most literature on pulsatile V-A ECMO focuses on hemodynamic energy production, whereas its potential clinical effects such as favorable heart and brain function, end-organ microcirculation, and decreased inflammation remain inconclusive and limited.
- 23 July 2021
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (5) , 623-632
Surface Coatings for Rotary Ventricular Assist Devices: A Systematic Review
Rotary ventricular assist devices (VADs) are frequently used to provide mechanical circulatory support to patients suffering from end-stage heart failure. Therefore, these devices and especially their pump impeller and housing components have stringent requirements on wear resistance and hemocompatibility. Various surface coatings have been investigated to improve the wear resistance or hemocompatibility of these devices. The aim of the present systematic review was to build a comprehensive understanding of these coatings and provide potential future research directions. A Boolean search for peer-reviewed studies was conducted in online databases (Web of Science, Scopus, PubMed, and ScienceDirect), and a preferred reporting items for systematic reviews and meta-analyses (PRISMA) process was followed for selecting relevant papers for analysis. A total of 45 of 527 publications were included for analysis. Eighteen coatings were reported to improve wear resistance or hemocompatibility of rotary VADs with the most common coatings being diamond-like carbon (DLC), 2-methacryloyloxyethyl phosphorylcholine (MPC), and heparin. Ninety-three percent of studies focused on hemocompatibility, whereas only 4% of studies focused on wear properties. Thirteen percent of studies investigated durability. This review provides readers with a systematic catalogue and critical review of surface coatings for rotary VADs. The review has identified that more comprehensive studies especially investigations on wear properties and durability are needed in future work.
- 23 July 2021
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (5) , 623-632
Surface Coatings for Rotary Ventricular Assist Devices: A Systematic Review
Rotary ventricular assist devices (VADs) are frequently used to provide mechanical circulatory support to patients suffering from end-stage heart failure. Therefore, these devices and especially their pump impeller and housing components have stringent requirements on wear resistance and hemocompatibility. Various surface coatings have been investigated to improve the wear resistance or hemocompatibility of these devices. The aim of the present systematic review was to build a comprehensive understanding of these coatings and provide potential future research directions. A Boolean search for peer-reviewed studies was conducted in online databases (Web of Science, Scopus, PubMed, and ScienceDirect), and a preferred reporting items for systematic reviews and meta-analyses (PRISMA) process was followed for selecting relevant papers for analysis. A total of 45 of 527 publications were included for analysis. Eighteen coatings were reported to improve wear resistance or hemocompatibility of rotary VADs with the most common coatings being diamond-like carbon (DLC), 2-methacryloyloxyethyl phosphorylcholine (MPC), and heparin. Ninety-three percent of studies focused on hemocompatibility, whereas only 4% of studies focused on wear properties. Thirteen percent of studies investigated durability. This review provides readers with a systematic catalogue and critical review of surface coatings for rotary VADs. The review has identified that more comprehensive studies especially investigations on wear properties and durability are needed in future work.
- 4 February 2021
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (10) , 1125-1133
A Compliant Model of the Ventricular Apex to Study Suction in Ventricular Assist Devices
Ventricular suction is a frequent adverse event in patients with a ventricular assist device (VAD). This study presents a suction module (SM) embedded in a hybrid (hydraulic-computational) cardiovascular simulator suitable for the testing of VADs and related suction events. The SM consists of a compliant latex tube reproducing a simplified ventricular apex. The SM is connected on one side to a hydraulic chamber of the simulator reproducing the left ventricle, and on the other side to a HeartWare HVAD system. The SM is immersed in a hydraulic chamber with a controllable pressure to occlude the compliant tube and activate suction. Two patient profiles were simulated (dilated cardiomyopathy and heart failure with preserved ejection fraction), and the circulating blood volume was reduced stepwise to obtain different preload levels. For each simulated step, the following data were collected: HVAD flow, ventricular pressure and volume, and pressure at the inflow cannula. Data collected for the two profiles and for decreasing preload levels evidenced suction profiles differing in terms of frequency (intermittent vs. every heart beat), amplitude (partial or complete stoppage of the HVAD flow), and shape. Indeed different HVAD flow patterns were observed for the two patient profiles because of the different mechanical properties of the simulated ventricles. Overall, the HVAD flow patterns showed typical indicators of suctions observed in clinics. Results confirmed that the SM can reproduce suction phenomena with VAD under different pathophysiological conditions. As such, the SM can be used in the future to test VADs and control algorithms aimed at preventing suction phenomena.
- 4 February 2021
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (10) , 1125-1133
A Compliant Model of the Ventricular Apex to Study Suction in Ventricular Assist Devices
Ventricular suction is a frequent adverse event in patients with a ventricular assist device (VAD). This study presents a suction module (SM) embedded in a hybrid (hydraulic-computational) cardiovascular simulator suitable for the testing of VADs and related suction events. The SM consists of a compliant latex tube reproducing a simplified ventricular apex. The SM is connected on one side to a hydraulic chamber of the simulator reproducing the left ventricle, and on the other side to a HeartWare HVAD system. The SM is immersed in a hydraulic chamber with a controllable pressure to occlude the compliant tube and activate suction. Two patient profiles were simulated (dilated cardiomyopathy and heart failure with preserved ejection fraction), and the circulating blood volume was reduced stepwise to obtain different preload levels. For each simulated step, the following data were collected: HVAD flow, ventricular pressure and volume, and pressure at the inflow cannula. Data collected for the two profiles and for decreasing preload levels evidenced suction profiles differing in terms of frequency (intermittent vs. every heart beat), amplitude (partial or complete stoppage of the HVAD flow), and shape. Indeed different HVAD flow patterns were observed for the two patient profiles because of the different mechanical properties of the simulated ventricles. Overall, the HVAD flow patterns showed typical indicators of suctions observed in clinics. Results confirmed that the SM can reproduce suction phenomena with VAD under different pathophysiological conditions. As such, the SM can be used in the future to test VADs and control algorithms aimed at preventing suction phenomena.
- Open Access
Open-source automated centrifugal pump test rig
- 31 August 2020
- Published by Wiley in Artificial Organs
- Vol. 45 (2) , E14-E25
Assessing potential for aortoiliac vascular injury from venoarterial extracorporeal membrane oxygenation cannulae: An in vitro particle image velocimetry study
Background Limb ischemia is a major complication associated with peripheral veno‐arterial extracorporeal membrane oxygenation (VA ECMO). The high velocity jet from arterial cannulae can cause “sandblasting” injuries to the arterial endothelium, with the potential risk of distal embolization and end organ damage. Aim The aim of this study was to identify, for a range of clinically relevant VA ECMO cannulae and flow rates, any regions of peak flow velocity on the aortic wall which may predispose to vascular injury, and any regions of low velocity flow which may predispose to thrombus formation. Methods A silicone model of the aortic and iliac vessels was sourced and the right external iliac artery was cannulated. Cannulae ranged from 15 – 21 Fr in size. Simulated steady state ECMO flow rates were instituted using a magnetically levitated pump (CentriMag pump). Adaptive particle image velocimetry was performed for each cannula at 3, 3.5, 4 and 4.5 L/min. Results For all cannulae, in both horizontal and vertical side hole orientations, the peak velocity on the aortic wall ranged from 0.3 m/s ‐ 0.45 m/s, and the regions of lowest velocity flow were 0.05 m/s. The magnitude of peak velocity flow on the aortic wall was not different between a single pair versus multiple pairs of side holes. Maximum velocity flow on the aortic wall occurred earlier at a lower pump flow rate in the vertical orientation of distal side holes compared to a horizontal position. The presence of multiple paired side holes was associated with fewer low velocity flow regions, and some retrograde flow, in the distal abdominal aorta compared to cannulae with a single pair of side holes. Conclusion From this in vitro visualization study, the selection of a cannula design with multiple versus single pairs of side holes did not change the magnitude of peak velocity flow delivered to the vessel wall. Cannulae with multiple side holes were associated with fewer regions of low velocity flow in the distal abdominal aorta. Further in vivo studies, and ideally clinical data would be required to assess any correlation of peak velocity flows with incidence of vascular injury, and any low velocity flow regions with incidence of thrombosis.
- 31 August 2020
- Published by Wiley in Artificial Organs
- Vol. 45 (2) , E14-E25
Assessing potential for aortoiliac vascular injury from venoarterial extracorporeal membrane oxygenation cannulae: An in vitro particle image velocimetry study
Background Limb ischemia is a major complication associated with peripheral veno‐arterial extracorporeal membrane oxygenation (VA ECMO). The high velocity jet from arterial cannulae can cause “sandblasting” injuries to the arterial endothelium, with the potential risk of distal embolization and end organ damage. Aim The aim of this study was to identify, for a range of clinically relevant VA ECMO cannulae and flow rates, any regions of peak flow velocity on the aortic wall which may predispose to vascular injury, and any regions of low velocity flow which may predispose to thrombus formation. Methods A silicone model of the aortic and iliac vessels was sourced and the right external iliac artery was cannulated. Cannulae ranged from 15 – 21 Fr in size. Simulated steady state ECMO flow rates were instituted using a magnetically levitated pump (CentriMag pump). Adaptive particle image velocimetry was performed for each cannula at 3, 3.5, 4 and 4.5 L/min. Results For all cannulae, in both horizontal and vertical side hole orientations, the peak velocity on the aortic wall ranged from 0.3 m/s ‐ 0.45 m/s, and the regions of lowest velocity flow were 0.05 m/s. The magnitude of peak velocity flow on the aortic wall was not different between a single pair versus multiple pairs of side holes. Maximum velocity flow on the aortic wall occurred earlier at a lower pump flow rate in the vertical orientation of distal side holes compared to a horizontal position. The presence of multiple paired side holes was associated with fewer low velocity flow regions, and some retrograde flow, in the distal abdominal aorta compared to cannulae with a single pair of side holes. Conclusion From this in vitro visualization study, the selection of a cannula design with multiple versus single pairs of side holes did not change the magnitude of peak velocity flow delivered to the vessel wall. Cannulae with multiple side holes were associated with fewer regions of low velocity flow in the distal abdominal aorta. Further in vivo studies, and ideally clinical data would be required to assess any correlation of peak velocity flows with incidence of vascular injury, and any low velocity flow regions with incidence of thrombosis.
- 7 July 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (3) , 270-275
In vitro Hemocompatibility Evaluation of the HeartWare Ventricular Assist Device Under Systemic, Pediatric and Pulmonary Support Conditions
The development of adult use right ventricular assist devices (RVADs) and pediatric left ventricular assist devices (pediatric LVADs) have significantly lagged behind compared to adult use left ventricular assist devices (LVADs). The HeartWare ventricular assist device (HVAD) intended to be used for adult’s systemic support, is increasingly used off-label for adult pulmonary and pediatric systemic support. Due to different hemodynamics and physiology, however, the HVAD’s hemocompatibility profiles can be drastically different when used in adult pulmonary circulation or in children, compared to its intended usage state, which could have a direct clinical and developmental relevance. Taking these considerations in mind, we sought to conduct in vitro hemocompatibility testing of HVAD in adult systemic, pediatric systemic and adult pulmonary support conditions. Two HVADs coupled to custom-built blood circulation loops were tested for 6 hours using bovine blood at 37°C under adult systemic, pediatric systemic, and adult pulmonary flow conditions (flow rate = 5.0, 2.5, and 4.5 L/min; differential pressure = 100, 69, and 20 mm Hg, respectively). Normalized index of hemolysis for adult systemic, pediatric systemic, and adult pulmonary conditions were 0.0083, 0.0039, and 0.0017 g/100 L, respectively. No significant difference was seen in platelet activation for these given conditions. High molecular weight von Willebrand factor multimer degradation was evident in all conditions (p < 0.05). In conclusion, alterations in the usage mode produce substantial differences in hemocompatibility of the HVAD. These findings would not only have clinical relevance but will also facilitate future adult use RVAD and pediatric LVAD development.
- 7 July 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (3) , 270-275
In vitro Hemocompatibility Evaluation of the HeartWare Ventricular Assist Device Under Systemic, Pediatric and Pulmonary Support Conditions
The development of adult use right ventricular assist devices (RVADs) and pediatric left ventricular assist devices (pediatric LVADs) have significantly lagged behind compared to adult use left ventricular assist devices (LVADs). The HeartWare ventricular assist device (HVAD) intended to be used for adult’s systemic support, is increasingly used off-label for adult pulmonary and pediatric systemic support. Due to different hemodynamics and physiology, however, the HVAD’s hemocompatibility profiles can be drastically different when used in adult pulmonary circulation or in children, compared to its intended usage state, which could have a direct clinical and developmental relevance. Taking these considerations in mind, we sought to conduct in vitro hemocompatibility testing of HVAD in adult systemic, pediatric systemic and adult pulmonary support conditions. Two HVADs coupled to custom-built blood circulation loops were tested for 6 hours using bovine blood at 37°C under adult systemic, pediatric systemic, and adult pulmonary flow conditions (flow rate = 5.0, 2.5, and 4.5 L/min; differential pressure = 100, 69, and 20 mm Hg, respectively). Normalized index of hemolysis for adult systemic, pediatric systemic, and adult pulmonary conditions were 0.0083, 0.0039, and 0.0017 g/100 L, respectively. No significant difference was seen in platelet activation for these given conditions. High molecular weight von Willebrand factor multimer degradation was evident in all conditions (p < 0.05). In conclusion, alterations in the usage mode produce substantial differences in hemocompatibility of the HVAD. These findings would not only have clinical relevance but will also facilitate future adult use RVAD and pediatric LVAD development.